A strong alliance between GlaxoSmithKline, GlaxoWellcome and GlaxoSmithKline. The history of the two companies can be traced back to the middle of19th century. For more than a century, each company has established a world-class leading position in the field of medicine through continuous innovation and several mergers. The successful merger of the two pharmaceutical giants laid the foundation for GlaxoSmithKline to become the undisputed leader in the industry and occupy 7% of the global pharmaceutical market.
GlaxoSmithKline represents the highest level in the world in the four medical fields of anti-infection, central nervous system, respiration and gastrointestinal tract/metabolism, and ranks first in the field of vaccines. In addition, the company is also in a leading position in the world consumer health care market, and its products include over-the-counter drugs, oral care products and nutritious health drinks.
In 2004, the global sales of GlaxoSmithKline reached 20.3 billion pounds (US$ 37.2 billion), of which prescription drugs (including vaccines) exceeded 654.38+07 billion pounds (US$ 365.438+00 billion) and consumer health products reached 3.2 billion pounds (US$ 5.8 billion).
GlaxoSmithKline is headquartered in the United Kingdom, with the United States as its business operation center, and has more than 654.38+million outstanding employees with professional skills and professionalism around the world. The company has 82 production bases in 37 countries around the world, and its products are exported to the world.
GlaxoSmithKline is the world's leading R&D pharmaceutical and healthcare company, headquartered in the UK. The company has 654.38+10,000 outstanding employees with professional skills and professionalism in more than 0/00 countries around the world, with an annual output of 4 billion boxes of medicines and consumer health care products, and the products are all over the global market.